sb 203580 has been researched along with Aging, Premature in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachler, MA; Bagley, MC; Davis, T; Kipling, D; Wyllie, FS | 1 |
| Davis, T; Haughton, MF; Jones, CJ; Kipling, D | 1 |
2 review(s) available for sb 203580 and Aging, Premature
| Article | Year |
|---|---|
Evaluating the role of p38 MAP kinase in growth of Werner syndrome fibroblasts.
Topics: Aging; Aging, Premature; Cell Cycle; Cell Proliferation; Cellular Senescence; Enzyme Inhibitors; Fibroblasts; Growth; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Werner Syndrome | 2010 |
Prevention of accelerated cell aging in the Werner syndrome.
Topics: Actins; Aging, Premature; Cells, Cultured; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Inhibitors; Fibroblasts; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Pyridines; Telomerase; Telomere; Tumor Suppressor Protein p53; Werner Syndrome | 2006 |